✦ LIBER ✦

Phase I study of weekly gemcitabine as a radiation sensitizer for unresectable pancreatic cancer

✍ Scribed by Matthew M Poggi; Glenn S Kroog; Angelo Russo; Christine Muir; John Cook; Judith Smith; James B Mitchell; Laurie L Herscher

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase I Study of Daily Irinotecan as a R

✍ Christelle de la Fouchardière; Sylvie Négrier; Hugues Labrosse; Isabelle Martel 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 92 KB

Phase II study of gemcitabine combined w

✍ Ron Epelbaum; Edward Rosenblatt; Suheil Nasrallah; David Faraggi; Dianna Gaitini 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 89 KB

Gemcitabine, paclitaxel, and radiation f

✍ Howard Safran; Thomas Dipetrillo; David Iannitti; Daniel Quirk; Paul Akerman; De 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 49 KB

A phase I study of imexon plus gemcitabi

✍ Steven J. Cohen; Mark M. Zalupski; Manuel R. Modiano; Paul Conkling; Yehuda Z. P 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 275 KB

A Phase I Study of Cetuximab in Combinat

✍ A.B. Chakravarthy; J.D. Berlin; A.C. Lockhart; E. Chan; A. Parikh; V. Kordowski; 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 53 KB

A phase I/II study of gemcitabine-based

✍ Masashi Kanai; Kenichi Yoshimura; Masanori Asada; Atsushi Imaizumi; Chihiro Suzu 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 263 KB